Stock Price Quote

MERCURY LABORATORIES LTD.

NSE : NABSE : 538964ISIN CODE : INE947G01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE772.00-3.05 (-0.39 %)
PREV CLOSE ( ) 775.05
OPEN PRICE ( ) 775.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 37
TODAY'S LOW / HIGH ( )772.00 775.05
52 WK LOW / HIGH ( ) 770976
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-02 1982
Management Info
Sanjay Patel - Chairman Rajendra R Shah - Managing Director
Registered Office

Address 18, Shreeji Bhuvan,51, Mangaldas Road,Princess Street,
Mumbai,
Maharashtra-400002

Phone 022 66372841 / 22015441

Email mllbom@mtnl.net.in / mllbrd@mercurylabs.com / secretarial@mercurylabs.com

Website www.mercurylabs.com

Registrars Details
MUFG Intime India Pvt Ltd.
Geetakunu, 1, Bhakti Nagar Society,Behind ABS Tower,Old Padra Road,Vadodara
Listing : BSE, OTCEI

NEWS

11Feb Mercury Laboratories informs about out
Mercury Laboratories has informed that the Board of Directors at its mee..
05Nov Mercury Laboratories informs about bo
Pursuant to Regulation 29 of the Securities and Exchange Board of India..
04Oct Mercury Laboratories informs about 10
Mercury Laboratories has informed that the Investor Education and Protec..
25Sep Mercury Laboratories informs about clo
Mercury Laboratories has informed that pursuant to Securities and Exchan..
19Jul Mercury Laboratories informs about pre
Mercury Laboratories has informed that it enclosed newspaper copies of p..

Financials

in Millions
QTR Dec 25 ANNUAL 25
Net Profit9.9631.4500000000001
Gross Profit 14.29 46.6100000000001
Operating Profit 28.3180.8500000000001
Net Sales 183.5751.01

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Alkem Laboratories (BSE)
peergroup  5619.05 (2.91%)
M.Cap ( in Cr)67184.17
Astrazeneca Pharma I (BSE)
peergroup  8801.65 (1.49%)
M.Cap ( in Cr)22004.13
Fredun Pharma (BSE)
peergroup  1690.95 (7.18%)
M.Cap ( in Cr)907.37
Glenmark Pharma (BSE)
peergroup  2228.25 (5.26%)
M.Cap ( in Cr)62881.40
NGL Fine-Chem (BSE)
peergroup  2355.35 (4.68%)
M.Cap ( in Cr)1455.14

Shareholding Pattern

PROMOTERS 73.66%
NON-INSTITUTION 26.34%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Mercury Laboratories Ltd.

Mercury Laboratories Ltd. was incorporated in the year 1982. Its today's share price is 772. Its current market capitalisation stands at Rs 92.64 Cr. In the latest quarter, company has reported Gross Sales of Rs. 751.01 Cr and Total Income of Rs.761.7 Cr. The company's management includes Janki R Shah, Paresh Mistry, Dilip R Shah, Sanjay Patel, Jayantilal Raval, Rajendra R Shah, Krishna Shah.

It is listed on the BSE with a BSE Code of 538964 , NSE with an NSE Symbol of and ISIN of INE947G01011. It's Registered office is at 18, Shreeji Bhuvan,51, Mangaldas Road,Princess StreetMumbai-400002, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Naresh & Co, RJ Shah & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.